Adres
Uzmanlık Hizmetleri
Genel göz sağlığı
Akıllı lens
Göz lazer tedavileri
Çocuk Göz Muayenesi
Glokom cerrahisi
Göz kapağı estetiği
Makula ödemi
Göz kaşıntısı
Göz ağrısı
Göz kapağı iltihabı
İmkanlar
Online Doktor Danışma
Özgeçmiş
Prof. Dr. Ali Rıza Cenk Çelebi Hacettepe Üniversitesi Tıp Fakültesi mezunu olan Prof. Dr. Ali Rıza Cenk Çelebi, göz hastalıkları uzmanlık eğitimini de aynı kurumda tamamlamıştır. Harvard University Tıp Fakültesi’ne bağlı Massachusetts Eye and Ear Infirmary (MEEI) Kliniği’nde glokom üzerine üst ihtisas yapmış, ayrıca biyolojik veri bilimi alanında yüksek lisans ve medikal biyoteknoloji ile moleküler ve tıbbi genetik alanında doktora derecelerini almıştır.
Uzmanlık alanları arasında glokom, kornea ve oküler yüzey hastalıkları yer almaktadır. Cerrahi olarak katarakt ve premium göz içi lens cerrahisi, lazer refraktif cerrahi, kornea nakli, fonksiyonel blefaroplasti ve göz kapağı estetiği, izsiz gözyaşı kanalı cerrahisi, orbita cerrahileri ve şaşılık cerrahisi başlıca uygulama alanlarını oluşturur.
Prof. Dr. Çelebi, ulusal ve uluslararası birçok tıbbi derneğin aktif üyesidir. Aynı zamanda bir veri bilimi ve yapay zeka uzmanı olarak, oftalmoloji ile yapay zekanın kesişiminde yenilikçi projeler geliştirmekte ve bu alanlarda geleceğin klinik uygulamalarını şekillendirmektedir. Oftalmoloji ve yapay zeka konularında 100’ü aşkın bilimsel yayını bulunan Prof. Dr. Ali Rıza Cenk Çelebi, klinik pratiği, akademik üretkenliği ve multidisipliner yaklaşımıyla hem ulusal hem de uluslararası alanda tanınan bir isimdir.
Ücret Bilgisi
Muayene ücretlerini öğrenmek için ara
Görüşler
Görüşlerinizi Önemsiyoruz
Uzmanlar ile ilgili görüşlerinizi belirtmeden öncemoderasyon sürecimizhakkında daha fazlasını öğrenin.
Bu uzman ile ilgili herhangi bir değerlendirme yapılmamış.
Bu uzmanı tanıyorsan veya ziyaret ettiysen görüş ve önerini yazabilirsin.
Görüş EkleSosyal Medya ve Pubmed Hesapları
Mesleki Bilgiler
Deneyim Süresi
Nisan 2010 - Günümüz (15 yıl)
16 yıllık mesleki deneyim
Diploma Aldığı Kurum
Hacettepe Üniversitesi
Uzmanlık Aldığı Kurum
Hacettepe Üniversitesi Tıp Fakültesi
Harvard Üniversitesi Tıp Fakültesi
Deneyimler
İstinye Üniversitesi Liv Hospital Topkapı
Yabancı Diller
İngilizce
Almanca
Arapça
İtalyanca
İspanyolca
Fransızca
Yayınlar
1 Celebi AR. The Relationship between Age and the Intraoperative Complication Rate During Phacoemulsification Surgery. Aging Clinical and Experimental Research 2014; 26: 177-181
2 Celebi AR, Mirza GE. Age Related Change in Retinal Nerve Fiber Layer Thickness Measured with Spectral Domain Optical Coherence Tomography. Investigative Ophthalmology and Visual Sciences 2013; 54: 8095-8103
3 Celebi AR, Orkun O. A Rare Case of Tick Infestation of the Eyelid: Case Report and Literature Review. Revista Brasileira de Oftalmologia. 2016; 75: 144-146
4 Celebi AR, Ulusoy C, Mirza GE. The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie. 2014; 252: 619-626
5 Celebi AR, Sasani H. Differentiation of true anophthalmia from clinical anophthalmia using neuroradiological imaging. World Journal of Radiology. 2014; 6: 515-518
6 Celebi AR, Ozbey C, Mirza GE. The Role of Mast Cells in Vascularized Recurrent Pterygium. Arquivos Brasileiros de Oftalmologia. 2014; 77: 285-2877
7 Celebi AR, Petriçli İS, Hekimoğlu E, Demirel N, Baş AY. The Incidence and Risk Factors of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants in Turkey. Medical Science Monitor 2014; 20: 1647-1653
8 Celebi AR, Kadayifcilar S, Eldem B. Hyperbaric oxygen therapy in branch retinal artery occlusion in a 15-year-old boy with methylenetetrahydrofolate reductase mutation. Case Reports in Ophthalmological Medicine 2015; 2015: 64024
9 Celebi AR, Kiratli H, Soylemezoglu F. Evaluation of the “Hedgehog” Signalling Pathways in Squamous and Basal Cell Carcinomas of Eyelids and Conjunctiva. Oncology Letters 2016; 12:467-72
10 Kilavuzoglu AE, Gonen T, Çelebi AR, Sener AB, Cosar CB. Treatment of mixed astigmatism: Early clinical outcomes with Wavelight and Technolas excimer lasers Turkish Journal of Medical Sciences 2016; 46: 664-72
11 Celebi AR, Kilavuzoglu AE, Altiparmak UE, Cosar CB, Ozkiris A. Retinal Tear: An Unusual Complication of Ocular Toxoplasmosis. Open Medicine 2015; 10: 555-559
12 Celebi AR, Kilavuzoglu AE, Altiparmak UE, Cosar CB, Ozkiris A. Hyperbaric oxygen for the treatment of the rare combination of central retinal vein occlusion and cilioretinal artery occlusion. Diving and Hyperbaric Medicine. 2016; 46: 50-53
13 Celebi AR, Kilavuzoglu AE, Altiparmak UE, Cosar CB. Corneal Biomechanical Properties in Aspirin Users. Ophthalmic Research. 2016; 55: 199-204
14 Kilavuzoglu AE, Celebi AR, Altiparmak UE, Cosar CB. The Effect of Smoking on Corneal Biomechanics. Current Eye Research 2017; 42: 16-20
15 Celebi AR, Kilavuzoglu AE, Altiparmak UE, Cosar CB, Ozkiris A. Iris metastasis of gastric adenocarcinoma. World Journal of Surgical Oncology 2016; 14:71
16 Celebi AR, Mirza GE. Differences in Central Corneal Thickness between Spectral Domain Optical Coherence Tomography and Ultrasound Pachymetry in Patients with Dry Eye Disease. Journal of Ophthalmology 2016; 2016: 2623719
17 H Sasani, A Kayhan, IZ Gökbay, M Sasani, S Köse, A Gökce, D Karatas, ARC Celebi, GV Saracoglu Comparison of 3d reformat computed tomography images using different softwares: do they have an incremental value in 3D imaging? Biomedical Research 28 (1)
18 Celebi AR, Kilavuzoglu AE, Altiparmak UE, Cosar CB, Ozkiris A. The role of anterior segment optical coherence tomography in the management of an intra-corneal foreign body. Springerplus. 2016 Sep 13; 5(1):1559.
19 Beyatli S, Polat Y, Celebi AR Ocular associations of myelinated retinal nerve fibers: A study based on a case report Open Journal of Clinical & Medical Case Reports 2017;123320
20 Celebi ARC, Kilavuzoglu AE, Altiparmak UE, Cosar Yurteri CB. Age-related change in corneal biomechanical parameters in a healthy Caucasian population. Ophthalmic Epidemiolology 2018 Feb;25(1):55-62.
21 Bas AY, Demirel N, Koc E, Ulubas Isik D, Hirfanoglu İM, Tunc T; TR-ROP Study Group. Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units. Br J Ophthalmol. 2018 Mar 8. pii: bjophthalmol-2017-311789. doi:10.1136/bjophthalmol-2017-311789. [Epub ahead of print]
22 Kilavuzoglu AEB, Yurteri G, Guven N, Marsap S, Celebi ARC, Cosar CB. The effect of hemodialysis on intraocular pressure. Adv Clin Exp Med. 2018 Jan;27(1):105-110.
23 Onerci Celebi O, Celebi ARC. The effect of ocular lubricants containing benzalkonium chloride on nasal mucosal flora. Cutan Ocul Toxicol. 2018 Apr 6:1-4. doi: 10.1080/15569527.2018.1456549. [Epub ahead of print]
24 Celik O, Kalfa M, Celebi ARC, Cabuk B, Ceylan S. Granulomatosis With Polyangiitis as an Uncommon Cause of Panhypopituitarism. J Clin Rheumatol. 2019 Dec;25(8):e145-e146. doi: 10.1097/RHU.**** **** **** 0766
25 Onerci Celebi O, Celebi ARC.The Effect of Topical Ocular Anesthetic Proparacaine on Conjunctival and Nasal Mucosal Flora in Dry Eye Disease Patients. J Clin Med. 2018 Apr 9;7(4). pii: E73. doi: 10.3390/jcm7040073.
26 Celebi ARC. Knowledge and Awareness of Glaucoma in Subjects with Glaucoma and their Normal First-Degree Relatives. Med Hypothesis Discov Innov Ophthalmol. 2018 Spring;7(1):40-7.
27 Eriş E, Perente I, Vural E, Vural A, Seymen Z, Celebi ARC, Erdogan G, Ozkaya A, Artunay O. Evaluation of the effect of combined intravitreal ranibizumab injection and sub-tenon steroid injection in the treatment of resistant diabetic macular edema. Int Ophthalmol. 2019 Jul;39(7):1575-1580. doi: 10.1007/s10792-018-0977-0
28 Kilavuzoglu AE, Cosar CB, Celebi ARC, Altiparmak UE. Intraocular pressure based on dynamic bidirectional applanation and air-puff tonometry: A comparative study. Journal of Current Glaucoma Practice, 2019; 13: 68-73.
29 Vural E, Hazar L, Çağlayan M, Şeker Ö, Çelebi ARC. Peripapillary choroidal thickness in patients with vitamin D deficiency. Eur J Ophthalmol. 2021 Mar;31(2):578-583.
30 Karasu B, Kiray G, Eris E, Perente I, Cenk Celebi AR. Comparison of success between external and endonasal dacryocystorhinostomy in primary acquired nasolacrimal duct obstruction in Turkish cohort. North Clin Istanb. 2020 Jul 23;7(6):579-58431
31 Karasu B, Celebi ARC. An efficacy comparison of combination of different anti-vascular endothelial growth factors and photodynamic therapy in patients with pachychoroid neovasculopathy. Int Ophthalmol. 2021 Jun;41(6):1989-2000.
32 Bulut E, Celebi ARC, Dokur M, Dayi O. Analysis of trending topics in glaucoma articles from an altmetric perspective. Int Ophthalmol. 2021 Jun;41(6):2125-2137.
33 Celebi ARC, Park EA, Verticchio Vercellin AC, Tsikata E, Lee R, Shieh E, Antar H, Freeman M, Zhang J, Que C, Simavli H, McClurkin M, Guo R, Elze T, de Boer JF, Chen TC. Structure- Function Mapping Using a Three-Dimensional Neuroretinal Rim Parameter Derived From Spectral Domain Optical Coherence Tomography Volume Scans. Transl Vis Sci Technol. 2021 May 3;10(6):28.
34 Karasu B, Celebi ARC. Choroidal vascularity index: an enhanced depth optical coherence tomography-based parameter to determine vascular status in patients with proliferative and non-proliferative macular telangiectasia. Int Ophthalmol. 2021 Oct;41(10):3505-3513.
35 Celebi ARC, Onerci Celebi O. The effect of topical ocular moxifloxacin on conjunctival and nasal mucosal flora. Sci Rep. 2021 Jul 2;11(1):13782.
36 Vural E, Hazar L, Çağlayan M, Çelebi ARC. Evaluation of choroidal thickness in light- coloured eyes. Eur J Ophthalmol. 2021 Jul 3:11206721211029470.
37 Celebi ARC. Hyperbaric Oxygen Therapy for Central Retinal Artery Occlusion: Patient Selection and Perspectives. Clin Ophthalmol. 2021 Aug 13;15:3443-3457.
38 Uçakhan ÖÖ, Taşındı E, Toker E, Çiftçi F, Kurna SA, Acar M, Özçelik F, Çelebi ARC, Yıldız HE, Akova YA, Öncü ES, Özbek Z, Tuncer Z, Kocabeyoğlu S, Şeker B, Kaya D, Barakat M. Clinical Performance of Samfilcon A Contact Lenses in Intensive Digital Device Users: A Multicenter, Prospective Clinical Study. Ophthalmol Ther. 2021 Dec;10(4):957-972.
39 Karasu B, Celebi ARC. Predictive value of ectopic inner foveal layer without internal limiting membrane peeling for idiopathic epiretinal membrane surgery. Int Ophthalmol. 2022 Jun;42(6):1885-1896. doi: 10.1007/s10792-021-02186-1. Epub 2022 Jan 6. PMID: 34989953
40 Karasu B, Akbas YB, Aykut A, Celebi ARC. Comparison of Retinochoroidal Vascular and Structural Changes after Half-Dose Photodynamic Therapy versus Half-Fluence Photodynamic Therapy Based on Optical Coherence Tomography Angiography in Eyes with Chronic Central Serous Chorioretinopathy. Ophthalmologica. 2022;245(4):323-334. doi: 10.1159/000523704. Epub 2022 Mar 4. PMID: 35249031
41 Karasu B, Celebi ARC. The efficacy of different anti-vascular endothelial growth factor agents and prognostic biomarkers in monitoring of the treatment for myopic choroidal neovascularization. Int Ophthalmol. 2022 Sep;42(9):2729-2740. doi: 10.1007/s10792-022-02261-1. Epub 2022 Mar 31. PMID: 35357641
42 Karasu B, Akbas YB, Aykut A, Çelebi ARC. Subthreshold Photocoagulation, Laser Endpoint Management Based on Optical Coherence Tomography Angiography in Cases of Diabetic Macular Edema Refractory to Anti-VEGF. Klin Monbl Augenheilkd. 2022 Apr 22. doi: 10.1055/a-1792-3009. Online ahead of print. PMID: 35453154 English.
43 Celebi ARC, Bulut E, Sezer A. Artificial intelligence based detection of age-related macular degeneration using optical coherence tomography with unique image preprocessing. Eur J Ophthalmol. 2023 Jan;33(1):65-73. doi: 10.1177/11206721221096294. Epub 2022 Apr 25. PMID: 35469472
44 Karasu B, Akbas YB, Kaskal M, Aykut A, Celebi ARC. Long term results of three anti- vascular endothelial growth factor agents in pachychoroid neovasculopathy. Cutan Ocul Toxicol. 2022 Jun;41(2):145-154. doi: 10.1080/15569527.2022.2068150. Epub 2022 May 30. PMID: 35579866
45 Altinbas E, Elibol A, Fıratlı G, Ayhan C, Celebi ARC. Assessment of risk factors on eye dryness in young adults using visual display device in both contact lens wearers and non- wearers. Int Ophthalmol. 2023 Feb;43(2):441-450. doi: 10.1007/s10792-022-02441-z. Epub 2022 Aug 3. PMID: 35920942
46 Karasu B, Kesim E, Kaskal M, Celebi ARC. Efficacy of topical dexamethasone eye drops in preventing ocular inflammation and cystoid macular edema following uncomplicated cataract surgery with or without injection of a single dose perioperative subtenon triamcinolone acetonide. Cutan Ocul Toxicol. 2022 Dec;41(4):310-317. doi: 10.1080/15569527.2022.2136193. Epub 2022 Oct 29. PMID: 36308286
47 Tunç U, Çelebi AC, Ekren BY, Yıldırım Y, Kepez Yıldız B, Okullu SÖ, Sezerman OU. Corneal bacterial microbiome in patients with keratoconus using next-generation sequencing-based 16S rRNA gene analysis. Exp Eye Res. 2023 Mar;228:109402. doi: 10.1016/j.exer.2023.109402. Epub 2023 Jan 31. PMID: 36736649
48 Celebi ARC, Aygun EG. A rare cause of recurrent subconjunctival hemorrhage: ocular vicarious menstruation. GMS Ophthalmol Cases. 2023 Jan 30;13:Doc05. doi: 10.3205/oc000213. eCollection 2023. PMID: 36875630
49 Firatli G, Elibol A, Altinbas E, Ayhan C, Celebi ARC. The Comparison of Age-related Change in Retinal Nerve Fiber Layer and Ganglion Cell Complex Thicknesses between Glaucoma Suspects and Healthy Individuals. J Curr Glaucoma Pract. 2023 Jan-Mar;17(1):22-29. doi:10.5005/jp-journals-10078-1392. PMID: 3722830550
50 Karasu B, Kesim E, Celebi ARC. The efficacy of different anti-vascular endothelial growth factor agents, and dexamethasone implant therapy in patients with serous retinal detachment caused by Irvine-Gass syndrome. Eur J Ophthalmol. 2023 Jul 5:11206721231185909. doi: 10.1177/11206721231185909. Online ahead of print. PMID: 37408434
51 Özdemir S, Çakırlı E, Sürücü B, Aygüler Cİ, Üner B, Çelebi ARC. Preparation and Characterization Studies of Dorzolamide-Loaded Ophthalmic Implants for Treating Glaucoma. Turk J Pharm Sci. 2023 Jul 7;20(3):149-156. doi:10.4274/tjps.galenos.2022.95752. PMID: 37417193
52 Ural Fatihoğlu Ö, Vural E, Çelebi ARC. The Short-term Effect of 1% Tropicamide Drop on Pupillary Diameter and İntraocular Pressure Change in Patients With Pseudoexfoliation Material. J Glaucoma. 2023 Jul 25. doi: 10.1097/IJG.**** **** **** 2278. Online ahead of print. PMID: 37523644
53 Kılıççıoğlu A, Oncel D, Celebi ARC. Autoimmune Disease-Related Dry Eye Diseases and Their Placement Under the Revised Classification Systems: An Update. Cureus. 2023 Dec 10;15(12):e50276. doi: 10.7759/cureus.50276. eCollection 2023 Dec. PMID: 38196419
54 Abduraman S, Celebi ARC. Ocular Toxoplasmosis. Medical Image Database 2024; 6 (1): 13-14
55 Basoz D, Celebi A, Buyuksungur S, Akalinli A, Yucel D, Hasirci N, Hasirci V. Construction of A Hydrogel Based 3D Bioprinted Corneal Stroma. Tissue EngineerinPart A. 2025; 30 (15-16): S8-S9.
56 Basoz D, Akalinli A, Buyuksungur S, Celebi ARC, Yucel D, Hasirci N, Hasirci V. Preclinical Testing of 3D Printed, Cell Loaded Hydrogel Based Corneal Substitutes on Rabbit Model. Macromol Biosci. 2025 Mar 27:e2400595. doi: 10.1002/mabi.202400595. Online ahead of print. PMID: 40145466
57 Toprak M, Kesim E, Karasu B, Celebi ARC Choroidal vascularity index findings in patients recovered from mild course COVID-19 pneumonia. Int. Ophthalmol. 2025 45 (1): 84
58 Abduraman S, Maliş B, Celebi ARC Taxane-associated retinopathy and radiation-induced optic neuropathy in a young female patient with metastatic breast cancer. German Medical Sciences GMS. 2025; 7: 15
Sık Sorulan Sorular
Prof. Dr. Ali Rıza Cenk Çelebi ile nasıl iletişime geçerim?
Prof. Dr. Ali Rıza Cenk Çelebi ile iletişime geçmek için bu telefon numarasını ara: +908504749112
Prof. Dr. Ali Rıza Cenk Çelebi için nasıl randevu alabilirim?
Prof. Dr. Ali Rıza Cenk Çelebi için online veya telefonla randevu alabilirsin.
Prof. Dr. Ali Rıza Cenk Çelebi hangi hastanede/klinikte çalışıyor, iletişim bilgileri nedir?
Prof. Dr. Ali Rıza Cenk Çelebi, İstinye Üniversitesi Liv Hospital Topkapı bünyesinde çalışmaktadır. Uzmanının iletişim bilgilerine profilinden ulaşabilirsiniz
Prof. Dr. Ali Rıza Cenk Çelebi kimdir, hangi uzmanlık alanında hizmet veriyor?
Prof. Dr. Ali Rıza Cenk Çelebi, Göz Hastalıkları uzmanıdır. Akıllı Lens, Katarakt Ameliyatı, Alerji, Çocuk Göz Muayenesi, Glokom, Göz Kapağı Ameliyatları, Gözyaşı kanal tıkanıklığı ameliyatları, Göz Kuruluğu, Az görme, Baş Ağrıları alanlarında hizmet veriyor.
Prof. Dr. Ali Rıza Cenk Çelebi muayene ücreti ne kadar?
Prof. Dr. Ali Rıza Cenk Çelebi muayene ücreti için +908504749112 numaralı randevu hattı ile iletişime geçin.